Wedge Capital Management’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
– Sell
-13,412
Closed -$304K – 588
2016
Q3
$304K Sell
13,412
-2,061
-13% -$45K ﹤0.01% 504
2016
Q2
$293K Buy
15,473
+50
+0.3% +$1.04K ﹤0.01% 504
2016
Q1
$403K Sell
15,423
-502
-3% -$11.6K ﹤0.01% 465
2015
Q4
$410K Sell
15,925
-1,350
-8% -$36.4K ﹤0.01% 470
2015
Q3
$388K Buy
17,275
+2,050
+13% +$52.6K ﹤0.01% 478
2015
Q2
$455K Buy
+15,225
New +$429K ﹤0.01% 459

Other funds holding TBI

Wedge Capital Management's TBI Position: Q4 2016 in Review

Wedge Capital Management sold out of Trueblue (TBI) in Q4 2016, closing a stake of 13,412 shares — an estimated $304K sold.

Wedge Capital Management first reported a position in TBI in Q2 2015 and held it in 6 quarters. The position peaked at $455K in Q2 2015. 183 funds tracked by Wall St. Rank hold TBI as of Q4 2016.

  • Wedge Capital Management reported no remaining Trueblue position as of Q4 2016 after selling out during the quarter.
  • Wedge Capital Management sold 13,412 Trueblue shares in Q4 2016, an estimated $304K.
  • Wedge Capital Management first reported a position in Trueblue in Q2 2015 and held it in 6 quarters.
  • Wedge Capital Management's Trueblue position peaked at $455K in Q2 2015.
  • 183 funds tracked by Wall St. Rank held Trueblue as of Q4 2016.

Based on Wedge Capital Management's 13F filing for Q4 2016, filed 31 Jan 2017.